W. David J. Ryder

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan et al. · The Lancet Oncology · 2021 · 749 citations · Full text

Medicine, Oncology, Pharmacology +8

Alternate splicing produces a novel cyclin D1 transcript.

DC Betticher, N. Thatcher, H. J. Altermatt et al. · PubMed · 1995 · 399 citations

Life Sciences, Genetics, Molecular Biology +7

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

Alison Clayton, Sarah Danson, Sanjay Jolly et al. · British Journal of Cancer · 2004 · 385 citations · Full text

Medicine, Neurology, Oncology +17

The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index

Andreas Jostel, W. David J. Ryder, Stephen M. Shalet · Clinical Endocrinology · 2009 · 235 citations

Medicine, Endocrinology, Endocrine Nuclear Medicine +16

Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency

Sacha J. Howell, John Radford, W. David J. Ryder et al. · Journal of Clinical Oncology · 1999 · 161 citations

Medicine, Endocrinology, Oncology +17